ADMA Biologics Inc Other Non-Current Liabilities 2013-2024 | ADMA

ADMA Biologics Inc other non-current liabilities for the quarter ending June 30, 2024 were $0.002B, a 3.02% increase year-over-year.

  • ADMA Biologics Inc other non-current liabilities for 2023 were $0.002B, a 13.89% increase from 2022.
  • ADMA Biologics Inc other non-current liabilities for 2022 were $0.002B, a 365.99% increase from 2021.
  • ADMA Biologics Inc other non-current liabilities for 2021 were $0B, a 621.82% increase from 2020.

ADMA Biologics Inc Other Non-Current Liabilities 2013-2024 | ADMA

  • ADMA Biologics Inc other non-current liabilities for 2023 were $0.002B, a 13.89% increase from 2022.
  • ADMA Biologics Inc other non-current liabilities for 2022 were $0.002B, a 365.99% increase from 2021.
  • ADMA Biologics Inc other non-current liabilities for 2021 were $0B, a 621.82% increase from 2020.